Skip to main content
. Author manuscript; available in PMC: 2013 Apr 3.
Published in final edited form as: JAMA. 2012 Oct 3;308(13):1357–1365. doi: 10.1001/jama.2012.12607

Table 1.

Screening Characteristics

Baseline Characteristics# Treatment Sequence
Mexiletine then Placebo N=29 Placebo then Mexiletine N=30
Age in Years - Mean (Range) 41.1 (16–66) 44.7 (22–68)
Gender: Male - No. (%) 13 (44.8) 20 (66.7)
Race: White - No. (%) 28 (96.6) 29 (100.0)
Ethnicity: Hispanic - No. (%) 4 (13.8) 9 (30.0)
Medication: Mexiletine - No. (%) 7 (24.1) 6 (20.0)
Medication: Other - No. (%) 3 (10.3) 1 (3.3)
IVR – Stiffness - Mean (SD) 3.89 (2.39) 4.63 (2.99)
SF-36 – Physical Norm-Based - Mean (SD) 38.7 (9.65) 40.8 (11.0)
SF-36 Mental Component - Mean (SD) 44.5 (13.3) 47.6 (9.8)
INQol – QOL Score - Mean (SD) 14.0 (9.03) 15.9 (12.5)
Clinical Hand Opening Time in Seconds – Geometric-like Mean (pseudo SD)¥ 1.11 (0.898, 3.48) 0.605 (0.510, 1.84)
Clinical Eye opening Time in Seconds - Geometric-like Mean (pseudo SD)¥ 0.507 (0.486, 2.42) 0.466 (0.455, 2.31)
Abductor Digiti Minimi EMG grade 3+ - No. (%)¤ 18 (62.1) 18 (62.1)
Short Exercise Test (% of Baseline) - Mean (SD) £ 78.7 (24.5) 80.8 (28.7)
Tibialis Anterior EMG grade 3+ - No. (%)¤ 20 (69.0) 19 (65.5)
Quantitative Handgrip Myotonia in Seconds - Geometric-like Mean (pseudo SD)¥ 0.651 (0.288, 0.518) 0.507 (0.211, 0.361)
Mutation – Chloride - No. (%) 17 (58.6) 17 (56.7)
Mutation – Sodium - No. (%) 10 (34.5) 11 (36.7)
Mutation – No Identified Mutation – No. (%) 2 (6.9) 2 (6.7)

SD = standard deviation

No. = number of participants

#

Reference ranges for the scales used in this study are as follows: for the interactive voice response diary (IVR) 0=no symptom, 1=’minimal, 9= ‘worst ever experienced14; SF36 Physical and Mental composite employs a linear T-score transformation 0–100 scale with US mean = 50, lower = larger impact22; the Individualized Neuromuscular Quality of Life scores are presented as a percentage of the maximum detrimental impact, a higher score indicates greater impact, with the exception of treatment effects, where a higher score indicates perceived effectiveness20; clinical hand opening time and eye opening time increase with increasing myotonia; the EMG grade ranges from 0 for no myotonia, 1+ for meeting minimal electrographic criteria for myotonia to 3+ for myotonia in every needle position19; the % of baseline on short exercise testing will decrease with increasing myotonia18; quantitative handgrip myotonia evaluation is expected to increase with increasing myotonia15.

1 participant declined reporting their race

Very few (8) participants had a true baseline report of stiffness severity. Consequently, if unreported, day 1 report was used (40) and if that was unreported, day 2 report was used (10).

¤

1 participant missing Abductor Digiti Minimi EMG grade and Tibialis Anterior EMG grade

£

1 participant missing short exercise test results

1 participant missing QOL score

¥

geometric-like mean is the inverse transformation (exp[y]−0.1) of the mean of transformed (log[t+0.1]) times. The pseudo standard deviations are the widths of the inverse transformed interval between the mean and plus/minus one standard deviation from the mean, these being calculated on the transformed scale. 8 participants did not have baseline Quantitative Handgrip Myotonia test. None were missing for the clinical tests.

HHS Vulnerability Disclosure